Literature DB >> 29225130

On the G protein-coupling selectivity of the native A2B adenosine receptor.

Zhan-Guo Gao1, Asuka Inoue2, Kenneth A Jacobson3.   

Abstract

A2B adenosine receptor (A2BAR) activation induces Gs-dependent cyclic AMP accumulation. However, A2BAR G protein-coupling to other signaling events, e.g. ERK1/2 and calcium, is not well documented. We explored Gi, Gq/11 and Gs coupling in 1321 N1 astrocytoma, HEK293, and T24 bladder cancer cells endogenously expressing human A2BAR, using NECA or nonnucleoside BAY60-6583 as agonist, selective Gi, Gs and Gq/11 blockers, and CRISPR/Cas9-based Gq- and Gs-null HEK293 cells. In HEK293 cells, A2BAR-mediated ERK1/2 activity occurred via both Gi and Gs, but not Gq/11. However, HEK293 cell calcium mobilization was completely blocked by Gq/11 inhibitor UBO-QIC and by Gq/11 knockout. In T24 cells, Gi was solely responsible for A2BAR-mediated ERK1/2 stimulation, and Gs suppressed ERK1/2 activity. A2BAR-mediated intracellular calcium mobilization in T24 cells was mainly via Gi, although Gs may also play a role, but Gq/11 is not involved. In 1321 N1 astrocytoma cells A2BAR activation suppressed rather than stimulated ERK1/2 activity. The ERK1/2 activity decrease was reversed by Gs downregulation using cholera toxin, but potentiated by Gi inhibitor pertussis toxin, and UBO-QIC had no effect. EPACs played an important role in A2BAR-mediated ERK1/2 signaling in all three cells. Thus, A2BAR may: couple to the same downstream pathway via different G proteins in different cell types; activate different downstream events via different G proteins in the same cell type; activate Gi and Gs, which have opposing or synergistic roles in different cell types/signaling pathways. The findings, relevant to drug discovery, address some reported controversial roles of A2BAR and could apply to signaling mechanisms in other GPCRs. Published by Elsevier Inc.

Entities:  

Keywords:  A2B adenosine receptor; Adenosine receptor; Calcium; ERK1/2; G protein; GPCR

Mesh:

Substances:

Year:  2017        PMID: 29225130      PMCID: PMC5899946          DOI: 10.1016/j.bcp.2017.12.003

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  65 in total

1.  Cell logic for dual coupling of a single class of receptors to G(s) and G(i) proteins.

Authors:  R P Xiao
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

2.  Differential Tissue-Specific Function of Adora2b in Cardioprotection.

Authors:  Seong-wook Seo; Michael Koeppen; Stephanie Bonney; Merit Gobel; Molly Thayer; Patrick N Harter; Katya Ravid; Holger K Eltzschig; Michel Mittelbronn; Lori Walker; Tobias Eckle
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

Review 3.  Adenosine regulation of the immune response initiated by ischemia reperfusion injury.

Authors:  D Boros; J Thompson; D F Larson
Journal:  Perfusion       Date:  2015-05-18       Impact factor: 1.972

4.  Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C.

Authors:  A Herrlich; B Kühn; R Grosse; A Schmid; G Schultz; T Gudermann
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

5.  On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells.

Authors:  M Adelina Costa; A Barbosa; E Neto; A Sá-e-Sousa; R Freitas; J M Neves; T Magalhães-Cardoso; F Ferreirinha; P Correia-de-Sá
Journal:  J Cell Physiol       Date:  2011-05       Impact factor: 6.384

6.  A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways.

Authors:  Z Gao; T Chen; M J Weber; J Linden
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

7.  A2B adenosine receptor blockade inhibits growth of prostate cancer cells.

Authors:  Qiang Wei; Stefano Costanzi; Ramachandran Balasubramanian; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2013-01-15       Impact factor: 3.765

8.  Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.

Authors:  Ilze Bot; Henk de Vries; Suzanne J A Korporaal; Amanda C Foks; Martine Bot; Jacobus van Veldhoven; Mariëtte N D Ter Borg; Peter J van Santbrink; Theo J C van Berkel; Johan Kuiper; Adriaan P Ijzerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-28       Impact factor: 8.311

9.  Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts.

Authors:  Sara A Epperson; Laurence L Brunton; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2009-02-25       Impact factor: 4.249

10.  Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 "therapeutic window".

Authors:  Yingmin Zhu; Haijun Chen; Stephen Boulton; Fang Mei; Na Ye; Giuseppe Melacini; Jia Zhou; Xiaodong Cheng
Journal:  Sci Rep       Date:  2015-03-20       Impact factor: 4.379

View more
  14 in total

Review 1.  Heterotrimeric Gq proteins as therapeutic targets?

Authors:  Evi Kostenis; Eva Marie Pfeil; Suvi Annala
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

2.  Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein Subunits.

Authors:  Jan Hendrik Voss; Andhika B Mahardhika; Asuka Inoue; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-03

3.  Gaussian accelerated molecular dynamics (GaMD): principles and applications.

Authors:  Jinan Wang; Pablo R Arantes; Apurba Bhattarai; Rohaine V Hsu; Shristi Pawnikar; Yu-Ming M Huang; Giulia Palermo; Yinglong Miao
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2021-03-01

4.  Tritium-labeled agonists as tools for studying adenosine A2B receptors.

Authors:  Sonja Hinz; Wessam M Alnouri; Ulrich Pleiss; Christa E Müller
Journal:  Purinergic Signal       Date:  2018-05-11       Impact factor: 3.765

5.  Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging.

Authors:  Min Guo; Zhan-Guo Gao; Ryan Tyler; Tyler Stodden; Yang Li; Joseph Ramsey; Wen-Jing Zhao; Gene-Jack Wang; Corinde E Wiers; Joanna S Fowler; Kenner C Rice; Kenneth A Jacobson; Sung Won Kim; Nora D Volkow
Journal:  J Med Chem       Date:  2018-11-13       Impact factor: 7.446

6.  Mechanistic Insights into Specific G Protein Interactions with Adenosine Receptors.

Authors:  Jinan Wang; Yinglong Miao
Journal:  J Phys Chem B       Date:  2019-07-22       Impact factor: 2.991

Review 7.  Molecular Simulations and Drug Discovery of Adenosine Receptors.

Authors:  Jinan Wang; Apurba Bhattarai; Hung N Do; Sana Akhter; Yinglong Miao
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

Review 8.  Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity.

Authors:  Milka Koupenova; Katya Ravid
Journal:  Front Pharmacol       Date:  2018-01-30       Impact factor: 5.810

Review 9.  Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development.

Authors:  Kenneth A Jacobson; Dilip K Tosh; Shanu Jain; Zhan-Guo Gao
Journal:  Front Cell Neurosci       Date:  2019-03-28       Impact factor: 5.505

Review 10.  A2B Adenosine Receptor and Cancer.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.